Indian companies are increasingly pursuing strategic overseas acquisitions. They now focus on acquiring capabilities and technology rather ...

India is planning a second phase for its production-linked incentive programme. This new phase will support high-performing sectors and red...

Dr Reddy's Laboratories has launched its generic Sugammadex injection in the United States. This new product reverses muscle relaxant effec...

As per Sebi's T+1 settlement cycle, investors must buy a company's shares at least one trading day before the record date to ensure the sha...

Global brokerages remained selective on large-cap stocks following the latest round of quarterly earnings, with Citi reiterating its bullis...

Sun Pharma's June quarter results met analyst expectations, signaling future growth. The company is expanding its specialty and innovative ...

Markets extended their winning streak on Friday, supported by encouraging quarterly business updates. Nifty strengthened its bullish struct...

This week, 573 companies will announce their June quarter results, featuring prominent firms. Bharti Airtel and Nykaa are among those repor...

"Withdrawal of Product - Depopred2ML, Brinolar (BKC FREE), Brinzotim Eye Drops 5ML BKC FREE, Lotepred-5ML, Lotepred 1% Eye Drops SML, Lotep...

In an exchange filing, GSM Foils said the firing incident took place in the Naikpada area in Vasai-Virar, located near Mumbai. After gettin...

Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...

Lupin Limited announced the launch of its Sugammadex Injection in the United States. This follows approval from the US Food and Drug Admini...

Indian markets traded in a narrow range, settling marginally higher with mixed cues. Maruti Suzuki, ITC, and Vedanta shares are in focus du...

Piramal Pharma will focus on policy actions amid tariff concerns. Its global manufacturing network offers a significant advantage. The comp...

Torrent Pharma aims to become a top three Indian drug maker. The company is transitioning from generics to drug innovation for growth. Aman...

Gland Pharma secured USFDA approval for its sugammadex injection generic version. This drug reverses muscle relaxant effects used during su...

India's pharma and healthcare sector recorded 65 deals worth $13.9 billion in Q2 CY2026, with volumes falling 17% quarter-on-quarter to a f...